Jacobio Pharmaceuticals CEO on Hong Kong IPO, Biotech

The video discusses a pharmaceutical company's IPO, focusing on new drug development for cancer treatment. It highlights future plans for clinical trials in the US and China, partnerships with companies like AbbVie, and revenue strategies through licensing. The company aims to expand globally, overcoming regulatory challenges by aligning with US FDA standards. The discussion also covers investor sentiment and market strategies for biotech companies.

What is the primary focus of the company's new project funded by the IPO?

• Expanding into the European market

• Developing a vaccine for COVID-19

• Creating a Ship two inhibitor for lung and colon cancer

• Building new research facilities

How many projects does the company have in its early-stage pipeline?

• 10

• 5

• 15

• 20

What is the company's strategy to generate revenue before turning a profit?

• Licensing out projects to partners

• Selling shares in the stock market

• Increasing product prices

• Reducing operational costs

What distinguishes the company's market strategy from other Chinese pharmaceutical companies?

• Focusing solely on the Chinese market

• Acquiring smaller biotech firms

• Conducting in-house research and aiming for global projects

• Relying on government subsidies

What is the company's approach to overcoming regulatory challenges in non-Chinese jurisdictions?

• Partnering with local firms

• Aligning with US FDA standards

• Lobbying for regulatory changes

• Avoiding international markets